Background and purpose: 5-Hydroxytryptamine (5-HT) can enhance
human ureteral contractions. However, the mediating receptors have not
been clarified yet. The study sought to further characterize the
mediating receptors using several more selective antagonists and
agonists. Experimental approach: Human distal ureters were obtained from
88 patients undergoing cystectomy. The mRNA expression levels of 5-HT
receptors were examined using RT-qPCR experiments. The phasic
contractions of ureter strips, either spontaneous or evoked with
neurokinin, were recorded in an organ bath. Key results: Among the 13
5-HT receptors, 5-HT2A and 5-HT2C had the highest mRNA expression
levels. 5-HT (10-7–10-4 M) concentration-dependently increased the
frequency and baseline tension of phasic contractions. However, a
tachyphylaxis effect was observed. SB242084 (100 nM) and ketanserin (100
nM), which are 5-HT2C selective and non-selective antagonist,
respectively, shifted the 5-HT concentration-response curves (frequency
and baseline tension) rightward. 5-HT2C selective agonist, vabicaserin,
increased contraction frequency with an Emax of 35% of 5-HT. 5-HT2A
selective antagonist, volinanserin (100 nM), only reduced baseline
tension. The selective antagonists of 5-HT1A,1B, 1D, 2B, 3, 4, 5, 6, and
7 had no antagonism. Blockade of voltage-gated sodium channels,
α1-adrenergic receptors, adrenergic neurotransmission, and neurokinin-2
receptors using tetrodotoxin, tamsulosin, guanethidine, and Men10376,
respectively, and desensitizing sensory afferents using capsaicin (100
μM), significantly reduced 5-HT effects. Conclusion and implications:
5-HT enhanced ureteral phasic contractions mainly by activating 5-HT2C.
Activation of sympathetic nerve and sensory afferents partly contributed
to 5-HT effects. 5-HT and 5-HT2C receptors could be promising targets
for ureteral stone expulsion and ureteral colic relief.